30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Cutting Edge Spine Gains FDA Clearance of EVOL-SI Joint Fusion -

Cutting Edge Spine received FDA 510(k) clearance to market EVOL-SI, a sacroiliac joint fusion system. Product launch is underway. Surface modification on the device is intended to improve osseointegration through hydrophilicity and surface chemistry, while characteristic nano-roughness mediates bioactivity that affects tissue regeneration to yield early bone formation that supports mechanical stability. (Cutting Edge Spine, 8/20/19)